NLST lung cancer distribution during screening and post-screening
1. Frequency of nodule as a function of associated risk factors
2. Frequency of lung cancer as a function of associated risk factors
3. Stage distribution given diagnosis of lung cancer
4. Frequency of survival given size, stage, and cell-type distribution
1) David Yankelevitz, Tisch Cancer Center, Mount Sinai School of Medicine
2) Claudia Henschke, Tisch Cancer Center, Mount Sinai School of Medicine
3) Paolo Boffetta, Institute for Translational Epidemiology, Mount Sinai School of Medicine
Lung Cancers Manifesting as Part-Solid Nodules in the National Lung Screening Trial.
Yip R, Henschke CI, Xu DM, Li K, Jirapatnakul A, Yankelevitz DF
AJR Am J Roentgenol. 2017 May; Volume 208 (Issue 5): Pages 1011-1021 PUBMED
Lung Cancer Deaths in the National Lung Screening Trial Attributed to Nonsolid Nodules.
Yip R, Yankelevitz DF, Hu M, Li K, Xu DM, Jirapatnakul A, Henschke CI
Radiology. 2016 Jul; Pages 152333 PUBMED
CT Screening for Lung Cancer: Alternative Definitions of Positive Test Result Based on the National Lung Screening Trial and International Early Lung Cancer Action Program Databases.
Yip R, Henschke CI, Yankelevitz DF, Smith JP
Radiology. 2014 Nov; Volume 273 (Issue 2): Pages 591-6 PUBMED
The impact of the regimen of screening on lung cancer cure: a comparison of I-ELCAP and NLST.
Yip R, Henschke CI, Yankelevitz DF, Boffetta P, Smith JP, The International Early Lung Cancer Investigators
Eur. J. Cancer Prev. 2014 Aug PUBMED